Title: Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate,
and tenofovir alafenamide fumarate in patients with hepatitis B: A network meta-analysis
Version: 4 Date: 10 Sep 2023
Reviewer's report:
In Figure 1, the font inside the blue box should be consistent.
In Figure 4, the authors should indicate the direction about the comparison of row-defining
treatment versus column-defining treatment in the annotation.
In Figure 7, the clarity of the picture needs to be improved. In addition, 6 month, 12 month, 24
month and 60 month should change to “6 months, 12 months, 24 months and 60 months”.
Title: Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate,
and tenofovir alafenamide fumarate in patients with hepatitis B: A network meta-analysis
Version: 4 Date: 10 Sep 2023
Reviewer's report:
In Figure 1, the font inside the blue box should be consistent.
In Figure 4, the authors should indicate the direction about the comparison of row-defining
treatment versus column-defining treatment in the annotation.
In Figure 7, the clarity of the picture needs to be improved. In addition, 6 month, 12 month, 24
month and 60 month should change to “6 months, 12 months, 24 months and 60 months”.
Please review this paper.
user
Title: Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate,
and tenofovir alafenamide fumarate in patients with hepatitis B: A network meta-analysis
Version: 4 Date: 10 Sep 2023
Reviewer's report:
In Figure 1, the font inside the blue box should be consistent.
In Figure 4, the authors should indicate the direction about the comparison of row-defining
treatment versus column-defining treatment in the annotation.
In Figure 7, the clarity of the picture needs to be improved. In addition, 6 month, 12 month, 24
month and 60 month should change to “6 months, 12 months, 24 months and 60 months”.
assistant